WH Partnership (WHP), one of the UK’s leading providers of integrated process and cleanrooms, designed and built Oxford BioMedica’s (OXB) new cleanroom production facility in Yarnton, Oxford. The plant, which manufactures unique gene-based medicines for its own clinical programmes and for some of the world’s largest pharmaceutical companies, develops pioneering products for diseases that currently have no treatment.
Constructed to comply with stringent UK Good Manufacturing Practice (GMP) regulations, the 560m2 of additional cleanroom space took less than a year from concept to completion and creates extra capacity for OXB and its existing and potential customers. The facility was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on first application to manufacture bulk drug material for Investigational Medicinal Products (IMPs). Crucially, this meant that OXB could begin manufacturing as soon as possible.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.
Subscribe now Already a subscriber? Sign in here.
